The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19

Clinical Trial ID NCT04357340

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04357340

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 18.32
2 A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020 7.78
3 Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax 2009 1.74
4 Chest physiotherapy revisited: evaluation of its influence on the pulmonary morbidity after pulmonary resection. Eur J Cardiothorac Surg 2011 1.57
5 Benefits and risks of manual hyperinflation in intubated and mechanically ventilated intensive care unit patients: a systematic review. Crit Care 2012 0.98
6 Feasibility of a structured 3-minute walk test as a clinical decision tool for patients presenting to the emergency department with acute dyspnoea. Emerg Med J 2009 0.90
7 Comparison of the distances covered during 3 and 6 min walking test. Respir Med 2002 0.79
8 Comprehensive physiotherapy management in ARDS. Minerva Anestesiol 2013 0.77
9 Intensive Care Physiotherapy during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. Ann Am Thorac Soc 2016 0.75
10 AARC Clinical Practice Guideline: Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients. Respir Care 2015 0.75
Next 100